Countermeasures are available for clinical management of neutropenia which include granulocyte-colony stimulating factor, G-CSF (Neupogen/Filgrastim)7 but currently there are no agents that received regulatory approval for rapid treatment of radiation or chemotherapy induced thrombocytopenia. The gene discussed is CSF3; the disease is Thrombocytopenia.